Morning Movers: Regional banks in focus after reporting Q3 results

Stock futures are mixed in early trading amid growing concerns over regional banks’ exposure to bad loans and broader credit quality risks. The session will cap a volatile week marked by U.S.–China tensions and the threat of a prolonged federal shutdown, while the dollar heads for its worst week since July on dovish Fed signals and renewed banking-sector worries.

In pre-market trading, S&P 500 futures declined 0.o6%, Nasdaq futures were down 0.25% and Dow futures rose 0.15%.

Check out this morning’s top movers from around Wall Street, compiled by The Fly. 

HIGHER –

• Revolution Medicines (RVMD) up 5% after daraxonrasib was included in the FDA’s Commissioner’s National Priority Review Voucher program
• Zions Bancorp (ZION) up 5% after being upgraded to Outperform at Baird
• Artiva Biotherapeutics (ARTV) up 107% after the company announced refractory rheumatoid arthritis as the lead indication for AlloNK and FDA Fast Track Designation
• Achieve Life Sciences (ACHV) up 23% after the company received the FDA’s Commissioner’s National Priority Voucher for cytisinicline

UP AFTER EARNINGS – 

• American Express (AXP) up 2%
• CSX (CSX) up 3%
• Fifth Third (FITB) up 2%
• Huntington Banchsares (HBAN) up 3%
• Truist Financial (TFC) up 2%

DOWN AFTER EARNINGS – 

• State Street (STT) down 4%

LOWER –

• Eli Lilly (LLY) down 4% after President Donald Trump said the price of Ozempic could come down based on negotiations with the federal government
• AST SpaceMobile (ASTS) down 3% after being double downgraded to Underweight at Barclays
• Micron (MU) down 1% after Reuters reported that the company plans to stop supplying its server chips to data centers in China
• Cryptocurrency-linked stocks declined as Bitcoin liquidations continue